Intranet PAC-CI
FR EN
PAC-CI Logo PAC-CI Contact us
PAC-CI Logo PAC-CI
Contact us

Blue November: PAC-CI mobilizes for men's health and prostate cancer screening

En cours

ELDORADO ANRS0392s

ELDORADO project logo

Project Details

Principal Investigator

  • Pr Beatriz GRINSZTEJN (Brésil), Dr Pierre SELLIER (France)

Chef de Projet

  • Anthony L.

Participating Countries

  • Brazil
  • Cameroon
  • Ivory Coast
  • France
  • Mozambique
  • Thailand

Duration

48 months

Study start

01 Jan 2025

Sponsor

ANRS|MIE

Research Team

The research team has not yet been filled in for this project.

Collaborate with us

We are open to partnerships with international research institutions and doctoral students.

Research Request

Estimated response time: 3-5 business days.

Keywords

OPERATIONS RESEARCH OUR PROJECTS TRANSVERSALE

Objectives

Main Objectives
To evaluate the non-inferiority of doravirine+TDF+3TC compared with dolutegravir+TDF+XTC in terms of virologic efficacy at week 48, as measured by the proportion of subjects achieving a viral load <50 copies/mL, in treatment-naive subjects infected with HIV-1 who had a pretreatment viral load of ≥ 1,000 copies/mL.
Exploration

Discover other projects

Tous les projets